Recently, accumulating evidences suggested that elevated serum GGT was involved in tumorigenesis and progression, such as gastric cancer [25], colorectal cancer [26], breast cancer [10] and cervical cancer [27]. This evidence concerns the gene GGT1 and breast carcinoma.